Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 12
2012 16
2013 1
2014 2
2015 3
2016 4
2017 18
2018 19
2019 25
2020 25
2021 31
2022 10
2023 14
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Results by year

Filters applied: . Clear all
Page 1
Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer.
Sperger JM, Helzer KT, Stahlfeld CN, Jiang D, Singh A, Kaufmann KR, Niles DJ, Heninger E, Rydzewski NR, Wang L, Wang L, Yang R, Ren Y, Engle JW, Huang P, Kyriakopoulos CE, Slovin SF, Soule HR, Zhao SG, Kohli M, Tagawa ST, Cai W, Dehm SM, Lang JM. Sperger JM, et al. Among authors: engle jw. Clin Cancer Res. 2023 Jun 13;29(12):2324-2335. doi: 10.1158/1078-0432.CCR-22-1305. Clin Cancer Res. 2023. PMID: 36939530 Free PMC article.
Ceria Nanoparticles Meet Hepatic Ischemia-Reperfusion Injury: The Perfect Imperfection.
Ni D, Wei H, Chen W, Bao Q, Rosenkrans ZT, Barnhart TE, Ferreira CA, Wang Y, Yao H, Sun T, Jiang D, Li S, Cao T, Liu Z, Engle JW, Hu P, Lan X, Cai W. Ni D, et al. Among authors: engle jw. Adv Mater. 2019 Oct;31(40):e1902956. doi: 10.1002/adma.201902956. Epub 2019 Aug 16. Adv Mater. 2019. PMID: 31418951 Free PMC article.
Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade.
Patel RB, Hernandez R, Carlson P, Grudzinski J, Bates AM, Jagodinsky JC, Erbe A, Marsh IR, Arthur I, Aluicio-Sarduy E, Sriramaneni RN, Jin WJ, Massey C, Rakhmilevich AL, Vail D, Engle JW, Le T, Kim K, Bednarz B, Sondel PM, Weichert J, Morris ZS. Patel RB, et al. Among authors: engle jw. Sci Transl Med. 2021 Jul 14;13(602):eabb3631. doi: 10.1126/scitranslmed.abb3631. Sci Transl Med. 2021. PMID: 34261797 Free PMC article.
The Production of Ac-225.
Engle JW. Engle JW. Curr Radiopharm. 2018;11(3):173-179. doi: 10.2174/1874471011666180418141357. Curr Radiopharm. 2018. PMID: 29669509 Review.
Fifty Years of Radiopharmaceuticals.
Brugarolas P, Comstock J, Dick DW, Ellmer T, Engle JW, Lapi SE, Liang SH, Parent EE, Kishore Pillarsetty NV, Selivanova S, Sun X, Vavere A, Scott PJH; Society of Nuclear Medicine and Molecular Imaging Radiopharmaceutical Sciences Council. Brugarolas P, et al. Among authors: engle jw. J Nucl Med Technol. 2020 Jun;48(Suppl 1):34S-39S. J Nucl Med Technol. 2020. PMID: 32605944 Free article. Review.
PET radiometals for antibody labeling.
Aluicio-Sarduy E, Ellison PA, Barnhart TE, Cai W, Nickles RJ, Engle JW. Aluicio-Sarduy E, et al. Among authors: engle jw. J Labelled Comp Radiopharm. 2018 Jul;61(9):636-651. doi: 10.1002/jlcr.3607. Epub 2018 Mar 12. J Labelled Comp Radiopharm. 2018. PMID: 29341227 Free PMC article. Review.
A Review of Accelerator-Produced Ga-68 with Solid Targets.
Becker KV, Chernysheva M, Barnhart TE, Gagnon K, Engle JW. Becker KV, et al. Among authors: engle jw. Curr Radiopharm. 2021;14(4):315-324. doi: 10.2174/1874471013666201224113651. Curr Radiopharm. 2021. PMID: 33357189 Review.
Labeling of Erythrocytes by Porphyrin-Phospholipid.
Kumar S, Jiang D, Sun B, Seeley KV, Engle JW, Sia Z, He X, Neelamegham S, Cai W, Lovell JF. Kumar S, et al. Among authors: engle jw. Adv Nanobiomed Res. 2021 Jan;1(1):2000013. doi: 10.1002/anbr.202000013. Epub 2020 Oct 16. Adv Nanobiomed Res. 2021. PMID: 34212160 Free PMC article.
167 results